Health care stocks were edging down Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing 0.2%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, Johnson & Johnson (JNJ) filed Tuesday a lawsuit seeking to stop the US Health Resources and Services Administration's attempts to block the company's rebate model under the federal 340B drug pricing program. Its shares added 0.2%.
Pulmatrix (PULM) shares surged more than 54% after the company said Wednesday it has reached a merger agreement with Cullgen.
Invizyne Technologies (IZTC) shares jumped 20% in recent trading in their Nasdaq debut.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.